United Kingdom (UK) NGS Based Molecular Diagnostic Market (2025-2031) | Segmentation, Outlook, Analysis, Companies, Forecast, Share, Value, Industry, Competitive Landscape, Size & Revenue, Trends, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) NGS Based Molecular Diagnostic Market - Industry Life Cycle

3.4 United Kingdom (UK) NGS Based Molecular Diagnostic Market - Porter's Five Forces

3.5 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume Share, By End Users, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders and chronic diseases in the UK driving the demand for NGS-based molecular diagnostics.

4.2.2 Technological advancements in NGS technologies leading to improved accuracy, efficiency, and cost-effectiveness of molecular diagnostic tests.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and approval processes for NGS-based diagnostic tests may hinder market growth.

4.3.2 High initial setup costs and ongoing maintenance expenses associated with NGS infrastructure and equipment.

6.1 United Kingdom (UK) NGS Based Molecular Diagnostic Market, By Application

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, By Microbiology, 2021- 2031F

6.1.4 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.1.5 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, By Oncology, 2021- 2031F

6.1.6 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, By Genetic Tests, 2021- 2031F

6.1.7 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, By Other Applications, 2021- 2031F

6.2 United Kingdom (UK) NGS Based Molecular Diagnostic Market, By End Users

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, By Research Centres and Academics, 2021- 2031F

6.2.3 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, By Hospitals and Clinical Laboratories, 2021- 2031F

6.2.4 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) NGS Based Molecular Diagnostic Market Export to Major Countries

7.2 United Kingdom (UK) NGS Based Molecular Diagnostic Market Imports from Major Countries

8.1 Adoption rate of NGS-based molecular diagnostic tests by healthcare facilities in the UK.

8.2 Number of research and development collaborations between diagnostic companies and academic institutions for advancing NGS technologies.

8.3 Rate of reimbursement approvals for NGS-based molecular diagnostic tests by insurance providers in the UK.

8.4 Number of new product launches and innovations in the NGS-based molecular diagnostic market in the UK.

8.5 Patient satisfaction and acceptance levels towards NGS-based molecular diagnostic testing in the UK healthcare system.

9.1 United Kingdom (UK) NGS Based Molecular Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United Kingdom (UK) NGS Based Molecular Diagnostic Market Opportunity Assessment, By End Users, 2021 & 2031F

10.1 United Kingdom (UK) NGS Based Molecular Diagnostic Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) NGS Based Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters